Anti-LDL Receptor antibody [EPR24874-56] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal LDL Receptor antibody. Carrier free. Suitable for WB and reacts with Human samples.
View Alternative Names
Low-density lipoprotein receptor, LDL receptor, LDLR
- WB
Lab
Western blot - Anti-LDL Receptor antibody [EPR24874-56] - BSA and Azide free (AB283723)
This data was developed using ab271189, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
LDLR is a glycosylated protein and can be deglycosylated by Protein Deglycosylation MIX II.
This blot was developed using a higher sensitivity ECL substrate.
Exposure time : 92 seconds
All lanes:
Western blot - Anti-LDL Receptor antibody [EPR24874-56] (<a href='/en-us/products/primary-antibodies/ldl-receptor-antibody-epr24874-56-ab271189'>ab271189</a>) at 1/1000 dilution
Lane 1:
Untreated Huh7 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 15 µg
Lane 2:
Huh7 whole cell lysate treated with Protein Deglycosylation MIX II at 15 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 95 kDa
Observed band size: 120 kDa,160 kDa
false
- WB
Lab
Western blot - Anti-LDL Receptor antibody [EPR24874-56] - BSA and Azide free (AB283723)
This data was developed using ab271189, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The expression profiles/observed MW are consistent with what has been described in the literature (PMID : 3005267).
Low expression : HEK-293 (PMID : 30617148).
Exposure time : 70 seconds
All lanes:
Western blot - Anti-LDL Receptor antibody [EPR24874-56] (<a href='/en-us/products/primary-antibodies/ldl-receptor-antibody-epr24874-56-ab271189'>ab271189</a>) at 1/1000 dilution
Lane 1:
PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
Huh7 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
HEK-293 (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 95 kDa
Observed band size: 120 kDa,160 kDa
false
- WB
Lab
Western blot - Anti-LDL Receptor antibody [EPR24874-56] - BSA and Azide free (AB283723)
This data was developed using ab271189, the same antibody clone in a different buffer formulation. Anti-LDLR antibody [EPR24874-56] (ab271189) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab271189 was shown to bind specifically to LDLR. A band was observed at 120, 150 kDa in wild-type HeLa cell lysates with no signal observed at this size in LDLR CRISPR-Cas9 edited cell line ab273838 (CRISPR-Cas9 edited cell lysate ab273792). The band observed in the CRISPR-Cas9 edited lysate lane below 120, 150 kDa is likely to represent a possible truncated form of LDLR. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and LDLR CRISPR-Cas9 edited HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween®20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-LDL Receptor antibody [EPR24874-56] (<a href='/en-us/products/primary-antibodies/ldl-receptor-antibody-epr24874-56-ab271189'>ab271189</a>) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human LDLR (LDL Receptor) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-ldlr-ldl-receptor-knockout-hela-cell-line-ab273838'>ab273838</a>)
Lane 2:
LDLR CRISPR-Cas9 edited HeLa cell lysate at 20 µg
Lane 3:
HepG2 cell lysate at 20 µg
Lane 4:
A431 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 95 kDa
Observed band size: 120 kDa,150 kDa
false
Related conjugates and formulations (1)
-
Anti-LDL Receptor antibody [EPR24874-56]
Reactivity data
Product details
ab283723 is the carrier-free version of ab271189.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The LDL receptor interacts with LDL particles to regulate cholesterol levels in the body. It is part of a cell surface complex that recognizes and binds to apolipoprotein B-100 or apolipoprotein E present on LDL. This interaction initiates internalization of LDL leading to its degradation in lysosomes where cholesterol can be released and used by the cell. Mutations in the gene encoding LDLR can lead to inefficient cholesterol uptake influencing various metabolic processes.
Pathways
LDL receptor activities are integral to lipid metabolism and cholesterol homeostasis. Two important biological pathways that involve LDLR include the cholesterol biosynthesis pathway and the lipoprotein clearance pathway. Within these pathways LDLR collaborates closely with proteins like PCSK9 which modulates its expression and degradation and HMG-CoA reductase an important enzyme in cholesterol synthesis to balance cholesterol levels in the body.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com